1. |
Lucon AM, Pereira MAA, Mendonca BB, et al. Pheochromocytoma: Study of 50 cases. J Urol, 1997, 157 (4): 1208-1212.
|
2. |
劉屹立, 徐彪, 孫強, 等. 不典型腎上腺嗜鉻細胞瘤. 中華泌尿外科雜志, 2006, 27(11): 725-727.
|
3. |
Dubois LA, Gray DK. Dopamine-secreting pheochromocytomas: in search of a syndrome. World J Surg, 2005, 29(7): 909-913.
|
4. |
Zelinka T, Widimsky J, Weisserova J. Diminished circadian blood pressure rhythm in patients with asymptomatic normotensive pheochromocytoma. Physiol Res, 2001; 50(6): 631-634.
|
5. |
楊紹波, 宮大鑫, 劉賢奎, 等. 腎上腺偶發嗜鉻細胞瘤. 中國醫科大學學報, 2004, 33(3): 276-277.
|
6. |
van der Harst E, de Herder WW, de Krijger RR, et al. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol, 2002, 147(1): 85-94.
|
7. |
姜元軍, 孫志熙, 宮大鑫, 等. 靜止型嗜鉻細胞瘤和非靜止型嗜鉻細胞瘤的比較. 臨床泌尿外科雜志, 2003, 118(4): 212-213.
|
8. |
Motta-Ramirez GA, Remer EM, Herts BR, et al. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. Am J Roentgenol, 2005, 185(3): 684-688.
|
9. |
Eisenhofer G, Keiser HR, Friberg P, et al. Plasma metanephrines are markers of phaeochromocytomaproduced by catechol-Omethyltransferase within tumours. J Clin Endocrinol Metab, 1998, 83(6): 2175-2185.
|
10. |
Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab, 2000, 85(2): 637-644.
|
11. |
Proye C, Fossati P, Fontaine P, et al. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery, 1986, 100(6): 1154-1162.
|
12. |
Gerlo EAM, Sevens C. Urinary and plasma catecholamines and urinary catecholamine metabolites in phaeochromocytoma: diagnostic value in 19 cases. Clin Chem, 1994, 40(2): 250-256.
|
13. |
Bachmann AW, Hawkins PG, Gordon RD. Phaeochromocytomas secreting adrenaline but not noradrenaline do not cause hypertension and require precise adrenaline measurement for diagnosis. Clin Exp Pharmacol Physiol, 1989, 16(4): 275.
|
14. |
Lipsic E, Balazovjech I, Kosmalova V, et al. Is the secretory pattern decisive for the clinical manifestation? J Endocrinol Invest, 2004, 27: 691-694.
|
15. |
Saginoya T, Miyake H, Kiyosue H, et al. Significance of CT findings and catecholamine determination in peripheral blood of asymptomatic pheochromocytoma and paraganglioma. Nippon Igaku Hoshasen Gakkai Zasshi, 2001, 61: 33-38.
|
16. |
Lenders JW, Pacak K, Eisenhofer G. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines. Ann N Y Acad Sci, 2002, 970: 29-40.
|
17. |
Saginoya T, Miyake H, Kiyosue H, et al. Significance of CT findings and catecholamine determination in peripheral blood of asymptomatic pheochromocytoma and paraganglioma. Nippon Igaku Hoshasen Gakkai Zasshi, 2001, 61: 33-38.
|
18. |
Lenders JWM, Pacak K, Walther MM, et al. JAMA, 2002, 287(11): 1427-1434.
|